Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Placebo-Controlled, Dose-Ranging Study of the Effects of TRx0014 30 MG TID, 60 MG TID AND 100 MG TID in Patients With Mild or Moderate Dementia of the Alzheimer Type

NCT00515333 is registered in ClinicalTrials.gov with TauRx Therapeutics Ltd as lead sponsor.

NCT NCT00515333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00515333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Placebo-Controlled, Dose-Ranging Study of the Effects of TRx0014 30 MG TID, 60 MG TID AND 100 MG TID in Patients With Mild or Moderate Dementia of the Alzheimer Type
Lead sponsor
TauRx Therapeutics Ltd
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2007
Enrollment
323 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, alzheimer type